GlaxoSmithKline will build on the Apple ResearchKit

[ad_1]

Last week, the US site Buzzfeed revealed that the Purdue Pharma laboratory was looking to use the Apple Medical API called ResearchKit to develop new drugs. It is the turn of the giant GlaxoSmithKline to announce similar ambitions.

During the presentation of its framework for the medical world in March, Apple first mentioned six Review applications designed by non-profit associations. However, the apple brand has never intended to exclude companies in the health sector provided it has "a positive impact on human health."

It is for this reason that the American laboratory GlaxoSmithKline had access to the development tool set up by the Cupertino company, and intends to use it in the coming months. This is reminiscent of a somewhat similar initiative announced a few weeks ago, which sees Johnson & Johnson and Medtronic recover data via ResearchKit via the IBM Waston Health cloud.

If GlaxoSmithKline officials have confirmed the project, we do not know exactly how it will materialize. The laboratory could, for example, retrieve the data of patients using its drugs to better study the consequences of each of them. Tim Cook presented ResearchKit as a tool that will allow institutions in the medical world to easily create applications to track patients on a daily basis, thanks to the data recorded by the iPhone. These are already 6 applications that are available and are based on ResearchKit and which aim to collect data to fight against asthma, Parkinson's disease, breast cancer or cardiovascular disease.

[ad_2]